Martinez et a1l mention two reports in which the undetermined group is higher than theirs. In one of them,9 the authors recognize the high proportion of nonidentified causes and attribute this to the fact that "the group is a combination of community and tertiary patient referrals." They also acknowledge that the frequency of cardioembolism may have been underestimated "because of local referral patterns." The other report10 is a study from 1978, a time when several causes of ischemic stroke, let alone deficiency of coagulation inhibitors, were still unrecognized.
Thirty-three percent of the patients in the Martinez study underwent echocardiography. In other series, echocardiography was performed in 52%,2 72.2%,3 63%,4 46%,6 92.7%,7 and 97%8 of the patients. It is to be noticed that of these studies, the one with the lowest number of echocardiograms performed is also the one with the highest proportion of strokes of undetermined origin.6 In our series, echocardiography was done in 62% of the cases.
The lower use of echocardiography in the Martinez study may have accounted for underestimation of cardioembolic stroke. The authors do not state whether echocardiography was performed in the 10 patients in whom a deficiency of coagulation inhibitors was described. On angiography, partial or total arterial occlusions were found in 8 of the patients. These could have been embolic, especially the branch occlusions (4 patients). Apparently, no repeat angiography was performed to corroborate the findings.
The authors state that "support for causal role of the hematologic disorder includes its persistence in subsequent months or identification of the abnormality in family members." In 3 patients the inhibitor deficiency normalized at the 3-month follow-up.
Cerebral ischemia may therefore have been due to other causes, especially in patient 3, who had heavy alcoholism, and patient 5, who took oral contraceptives and tested positive for antinuclear and anticardiolipin antibodies. All of these are recognized risk factors for stroke.
Coagulation inhibitor test results were normal in the patients' family members, whereas low values have been observed in the relatives of heterozygous patients with the disorder.11 No qualitative or functional assays are reported, and relatives were studied in only 6 of the 10 cases. But even if the patients in this study were heterozygous and did have the deficit, the association could be fortuitous and the stroke due to other causes. For protein C deficiency in particular, the prevalence of heterozygosity is said to be as high as 1 in 200 asymptomatic individuals, most without thrombosis.12
The precise role of coagulation inhibitors in stroke remains to be determined. Certainly, coagulation inhibitor deficiency may be an underrecognized cause of ischemic stroke. It may also be a consequence of it. 13 Therefore, it is difficult to attribute strokes to this deficiency when cardiac sources of embolism may have gone undetected, relatives of some of the patients studied do not have the deficit, other patients' family members are not tested, qualitative assays are not carried out, inhibitor values normalize in a follow-up test, and other risk factors and mechanisms may account for the ischemic event. In the patients studied in this letter, it would be more cautious to consider their strokes "associated with" rather than "due to" coagulation inhibitor deficiency.
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